Sirtuin polymorphisms and methods of use thereof

Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound and/or subjects that are suffering from or susceptible to a disease mediated by a sirtuin. Also provided are methods for determining the predictive value of a sirtuin polymorphic variant, methods for evaluating sirtuin modulating compounds, and methods for determining appropriate dosage and/or treatment regimens for subjects having one or more sirtuin polymorphic variants. Screening methods for identifying sirtuin modulating compounds using polymorphic variants of a sirtuin are also provided


Year:
2008
Note:
Applicant(s): Sirtris Pharm. Inc [US]
Other identifiers:
EPO Family ID: 39402184
Laboratories:




 Record created 2009-04-20, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)